Home NCI TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurrence May Forgo Chemotherapy TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurrence May Forgo Chemotherapy Cancer Info June 24, 2020 0 Comments Share: Facebook Twitter Google+ Pinterest Whatsapp A summary of results from the Trial Assigning Individualized Options for Treatment, or TAILORx, finds that women with early-stage hormone receptor-positive breast cancer have a low risk of recurrence based on a test for the expression of 21 genes.
No comments